DK2262503T3 - Formuleringer med sanguinarin, chelerythrin eller chelidonin til behandlingen af vorter, verrucas og psoriasis plaques - Google Patents

Formuleringer med sanguinarin, chelerythrin eller chelidonin til behandlingen af vorter, verrucas og psoriasis plaques

Info

Publication number
DK2262503T3
DK2262503T3 DK09718874.2T DK09718874T DK2262503T3 DK 2262503 T3 DK2262503 T3 DK 2262503T3 DK 09718874 T DK09718874 T DK 09718874T DK 2262503 T3 DK2262503 T3 DK 2262503T3
Authority
DK
Denmark
Prior art keywords
chelidonin
sanguinarin
verrucas
worts
chelerythrine
Prior art date
Application number
DK09718874.2T
Other languages
English (en)
Inventor
Gabriele Fontana
Paolo Morazzoni
Antonella Riva
Massimo Ronchi
Ezio Bombardelli
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Application granted granted Critical
Publication of DK2262503T3 publication Critical patent/DK2262503T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4741—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having oxygen as a ring hetero atom, e.g. tubocuraran derivatives, noscapine, bicuculline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Paints Or Removers (AREA)
  • Paper (AREA)
  • Polishing Bodies And Polishing Tools (AREA)
DK09718874.2T 2008-03-10 2009-03-09 Formuleringer med sanguinarin, chelerythrin eller chelidonin til behandlingen af vorter, verrucas og psoriasis plaques DK2262503T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000395A ITMI20080395A1 (it) 2008-03-10 2008-03-10 Formulazioni per il trattamento delle verruche e delle placche psoriatiche
PCT/EP2009/001672 WO2009112226A1 (en) 2008-03-10 2009-03-09 Formulations with sanguinarine, chelerythrine or chelidonine for the treatment of warts, verrucas and psoriatic plaques

Publications (1)

Publication Number Publication Date
DK2262503T3 true DK2262503T3 (da) 2014-05-19

Family

ID=40292856

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09718874.2T DK2262503T3 (da) 2008-03-10 2009-03-09 Formuleringer med sanguinarin, chelerythrin eller chelidonin til behandlingen af vorter, verrucas og psoriasis plaques

Country Status (17)

Country Link
US (2) US8226994B2 (da)
EP (1) EP2262503B1 (da)
JP (1) JP5535088B2 (da)
KR (1) KR20100126367A (da)
CN (1) CN101959517A (da)
AU (1) AU2009224936B2 (da)
CA (1) CA2718384C (da)
DK (1) DK2262503T3 (da)
ES (1) ES2467104T3 (da)
HR (1) HRP20140552T1 (da)
IL (1) IL208030A (da)
IT (1) ITMI20080395A1 (da)
PL (1) PL2262503T3 (da)
PT (1) PT2262503E (da)
RU (1) RU2486898C2 (da)
SI (1) SI2262503T1 (da)
WO (1) WO2009112226A1 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20080395A1 (it) * 2008-03-10 2009-09-11 Indena Spa Formulazioni per il trattamento delle verruche e delle placche psoriatiche
US20110218241A1 (en) * 2010-03-06 2011-09-08 Cacao Bio-Technologies, Llc Antiviral epicatechins, epicatechin oligomers, or thiolated epicatechins from theobroma cacao for treatment of genital warts
ITMI20112216A1 (it) 2011-12-05 2013-06-06 Fond Salvatore Maugeri Clinic A Del Lavoro E Composizione comprendente un estratto di chelidonium majus e copaiba e il suo impiego per il trattamento di disfunzioni cutanee
US11566260B2 (en) 2012-07-16 2023-01-31 Universite D'angers Potentiating agents for protecting plants from fungal infections
EP2687097A1 (en) * 2012-07-16 2014-01-22 Universite D'angers Potentiating agents for protecting plants from fungal infections
JP6211380B2 (ja) * 2012-10-17 2017-10-11 丸善製薬株式会社 Ｔｉｅ２活性化剤、血管新生抑制剤、血管の成熟化剤、血管の正常化剤、及び血管の安定化剤
KR101431987B1 (ko) * 2013-09-12 2014-08-22 중앙대학교 산학협력단 펠리토린을 유효성분으로 포함하는 접촉성 피부염 개선용 조성물
CN105641576A (zh) * 2014-12-06 2016-06-08 石万桃 一种治疗各种皮肤疣的外用药膏
CN104800216B (zh) * 2015-01-26 2019-03-22 东北师范大学 氯化两面针碱及其衍生物在制备防治皮肤病药物中的应用
IT201600097120A1 (it) * 2016-09-28 2018-03-28 Michele Miglio Formulazione topica per il trattamento della psoriasi

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4590061A (en) * 1983-12-29 1986-05-20 Vipont Laboratories, Inc. Antimicrobial plaque disclosing agent
HU194052B (en) * 1985-03-12 1988-01-28 Caola Kozmetikai Cosmetic composition against verrucae
US5165932A (en) * 1987-12-23 1992-11-24 Unipharma Co., Ltd. Therapeutical compositions against psoriasis
FR2661330B1 (fr) * 1990-02-07 1995-01-06 Marlene Azoulay Compose permettant des soins de manucure et pedicure et le traitement des cors aux pieds, durillons et verrues.
DE4031960A1 (de) * 1990-10-09 1992-04-16 Dieter Dr Wendorff Pharmazeutische zubereitung zur externen behandlung von schuppenflechte (psoriasis vulgaris)
US6355684B1 (en) * 1990-10-11 2002-03-12 Meryl J. Squires Antimicrobial treatment for herpes simplex virus and other infectious diseases
IT1254321B (it) * 1992-04-10 1995-09-14 Kemiprogress S R L Composizione farmaceutica per il trattamento e la prevenzione delle infiammazioni cutanee e della mucosa orale.
US6593371B1 (en) * 1993-05-19 2003-07-15 Jeff J. Staggs Treatment for wart and related disorders
FR2710266B1 (fr) * 1993-09-21 1995-11-17 Paul Dupont Nouvelles compositions en cosmétologie et dermatologie proposées dans le traitement des verrues.
ITMI981542A1 (it) * 1998-07-07 2000-01-07 Indena Spa Estratti di zanthoxylum bungeanum e loro formulazioni farmaceutiche e cosmetiche
US6558694B2 (en) * 1999-02-19 2003-05-06 Norman A. Brooks Zinc chloride unit dose packaging, applicator, and method of use in treating cancer and other skin diseases
US20020150630A1 (en) * 1999-02-19 2002-10-17 Brooks Norman A. Zinc chloride composition, unit dose packaging, applicator, and method of use in treating cancer and other skin diseases
HU227318B1 (en) * 2000-03-08 2011-03-28 Tibor Bodnar Cosmetical and dematological composition for treating, grooming of psoric skin and scalp
ITMI20032286A1 (it) * 2003-11-24 2005-05-25 Indena Spa Composizioni per il trattamento di dermatiti atopiche di stati allergici cutanei e dell'acne
DE102005049981A1 (de) * 2005-10-17 2007-04-19 Henkel Kgaa Prickelnde Mundwässer
DE102005060182A1 (de) * 2005-12-14 2007-06-21 Henkel Kgaa Remineralisierende Erzeugnisse
JP2007217410A (ja) * 2006-01-20 2007-08-30 Tsutomu Yoshida 抗ウイルス組成物、それを含む抗ウィルス剤及び抗ウイルス機能性食品
EP1882473A1 (en) * 2006-07-28 2008-01-30 Indena S.P.A. Use of anthocyanosides to prepare formulations for the treatment of mucositis induced by antitumoral drugs
ITMI20080395A1 (it) * 2008-03-10 2009-09-11 Indena Spa Formulazioni per il trattamento delle verruche e delle placche psoriatiche

Also Published As

Publication number Publication date
EP2262503B1 (en) 2014-04-30
JP2011513449A (ja) 2011-04-28
PT2262503E (pt) 2014-06-09
SI2262503T1 (sl) 2014-07-31
ITMI20080395A1 (it) 2009-09-11
US8226994B2 (en) 2012-07-24
AU2009224936B2 (en) 2014-11-13
WO2009112226A8 (en) 2009-11-12
US9393280B2 (en) 2016-07-19
IL208030A0 (en) 2010-12-30
CA2718384A1 (en) 2009-09-17
US20110014306A1 (en) 2011-01-20
KR20100126367A (ko) 2010-12-01
IL208030A (en) 2016-12-29
ES2467104T3 (es) 2014-06-11
CN101959517A (zh) 2011-01-26
CA2718384C (en) 2016-06-07
RU2010137335A (ru) 2012-03-20
WO2009112226A1 (en) 2009-09-17
PL2262503T3 (pl) 2014-09-30
US20120263810A1 (en) 2012-10-18
AU2009224936A1 (en) 2009-09-17
EP2262503A1 (en) 2010-12-22
HRP20140552T1 (hr) 2014-07-18
JP5535088B2 (ja) 2014-07-02
RU2486898C2 (ru) 2013-07-10

Similar Documents

Publication Publication Date Title
DK2262503T3 (da) Formuleringer med sanguinarin, chelerythrin eller chelidonin til behandlingen af vorter, verrucas og psoriasis plaques
DK2470191T3 (da) Fremgangsmåder og præparater til forebyggelse eller behandling af oftalmiske tilstande
DK2796469T3 (da) Hidtil ukendte sammensætninger og fremgangsmåder til behandling af IgE-medierede forstyrrelser
DK2504005T3 (da) Anvendelse af 1,3-diphenylprop-2-en-1-on-derivater til behandling af lever-sygdomme
DK2240155T3 (da) Indretninger, formuleringer og fremgangsmåder til levering af flere gavnlige midler
DK3517534T3 (da) Forbindelser, der er anvendelige til behandling af cancer
DK2220116T3 (da) Sammensætninger og fremgangsmåder til terapien og diagnosticeringen af influenza
DK2532680T3 (da) Medicinsk sammensætning til behandling og/eller forebyggelse af cancer
DK3461503T3 (da) Fremgangsmåder til indgivelse af tetrahydrobiopterin, associerede sammensætninger og målingsfremgangsmåder
DK2340042T3 (da) Fremgangsmåder og præparater til behandling af cancer
DK2475372T4 (da) Fremgangsmåde til fremstilling af micro-RNA og dets terapeutiske anvendelse
DK3192520T3 (da) Terapeutiske midler til reducering af niveauerne af parathyreoideahormon
DK2270818T3 (da) Polyelektrolyt og fremgangsmåde til fremstilling af polyelektrolytten
DK2498771T3 (da) Anvendelse af bethanechol til behandling af xerostomi
DK2451796T3 (da) Tofaanaloger til behandling af dermatologiske lidelser eller tilstande
DK2358669T3 (da) Alpha-keto-persyrer og fremgangsmåder til fremstilling og anvendelse heraf
DK2329182T3 (da) Horisontalt og vertikalt indstilleligt leje
EP2331123A4 (en) COMPOSITIONS AND METHODS FOR TREATING HEPATITIS C
DK2309916T3 (da) System og fremgangsmåde til ordination af synshjælpemidler
DK2235002T3 (da) 4-pyridinonforbindelser og anvendelse heraf til behandling af cancer
DK2432798T3 (da) 17-hydroxy-17-pentaflourethyl-estra-4,9(10)-dien-11-aryl-derivat, fremgangsmåde til fremstilling heraf og anvendelse heraf til behandling af sygdomme
DK2567690T3 (da) Anvendelse af amisulphrid til behandling af kemoterapi-induceret kvalme og opkast
DK2467364T3 (da) Nitrogen-holdige forbindelser og farmaceutiske sammensætninger for behandling af atrial flimren.
DK2216021T3 (da) Farmaceutisk sammensætning til behandling af overaktiv blære
EP2249823A4 (en) OCTANOIC ACID FORMULATION AND METHODS OF TREATMENT EMPLOYING THE SAME